Spontaneous reporting of adverse drug events by Korean Regional Pharmacovigilance Centers

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 10, 2009, Pages 910-915

  Shin, Yoo Seob ^a   Lee, Yong Won ^a   Choi, Young Hwa ^a,b   Park, Byungjoo ^a,c   Jee, Young Koo ^a,d   Choi, Sung Kyu ^a,e   Kim, Eung Gyu ^a,f   Park, Jung Won ^a   Hong, Chein Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Dankook University College of Medicine   (South Korea)

^e Chonnam National University Medical School   (South Korea)

^f Inje University College of Medicine   (South Korea)

Author keywords

Adverse drug reaction; Regional pharmacovigilance center; Spontaneous reporting

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; ANTINEOPLASTIC AGENT; ANTIOBESITY AGENT; ANTIRETROVIRUS AGENT; ANTITHYROID AGENT; ANTIULCER AGENT; CARDIOVASCULAR AGENT; CEPHALOSPORIN; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOSUPPRESSIVE AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXICAM DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; TETRACYCLINE; THEOPHYLLINE; TUBERCULOSTATIC AGENT; UNINDEXED DRUG; VANCOMYCIN; VITAMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HUMAN; KOREA; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 70450211173     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1796     Document Type: Article

References (21)

1. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324: 377-384.
2. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
3. Roughead EE, Gilbert AL, Primrose JG, et al. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998; 168: 405-408.
4. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301-306.
5. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond 1995; 29: 41-49.
6. Eliasson E. Ethnicity and adverse drug reactions. Br Med J 2006; 332: 1163-1164.
7. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 2006; 62: 143-149.
8. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 2001; 1: 305-310.
9. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356: 1255-1259. (Pubitemid 30769501)
10. Hunziker T, Kunzi UP, Braunschweig S, et al. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy 1997; 52: 388-393. (Pubitemid 27244150)
11. Thong BY, Leong KP, Tang CY, et al. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003; 90: 342-347.
12. Choi JH, Shin YS, Suh CH, Nahm DH, Park HS. The frequency of adverse drug reactions in a tertiary care hospital in Korea. Korean J Med 2004; 67: 290-296.
13. Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999; 159: 2553-2560.
14. Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients.1991. Qual Saf Health Care 2005; 14: 221-225 (Discussion 225-226).
15. Lacoste-Roussillon C, Pouyanne P, Haramburu F, et al. Incidence of serious adverse drug reactions in general practice: a prospective study. Clin Pharmacol Ther 2001; 69: 458-462. (Pubitemid 32554552)
16. Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med 2000; 15: 149-154.
17. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-1205. (Pubitemid 28193431)
18. Stricker BH, Psaty BM, Detection, verification, and quantification of adverse drug reactions. Br Med J 2004; 329: 44-47. (Pubitemid 38870007)
19. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med 1986; 314: 1589-1592.
20. Jick H. Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol 1984; 74: 555-557. (Pubitemid 15206318)
21. Berry LL, Segal R, Sherrin TP, et al. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm 1988; 45: 1534-1539. (Pubitemid 18187626)